Table 3.
SNR | CNR | |||||
---|---|---|---|---|---|---|
Coef | 95% Conf. Interval | p value | Coef | 95% Conf. Interval | p value | |
Contrast medium | ||||||
60 mL | Ref | Ref | ||||
50 mL | − 0.21 | − 6.24–5.82 | 0.946 | − 0.27 | − 6.17 to 5.64 | 0.930 |
40 mL | − 1.10 | − 7.23–5.04 | 0.726 | 0.00 | − 6.04 to 6.04 | 0.999 |
30 mL | − 12.92 | − 19.04 to − 6.81 | < 0.001 | − 13.86 | − 19.87 to − 7.85 | < 0.001 |
Reconstructions | ||||||
Standard | Ref | Ref | ||||
VMI 40 keV | 6.04 | 3.66–8.42 | < 0.001 | 0.71 | − 1.42 to 2.84 | 0.513 |
VMI 60 keV | − 9.80 | − 12.19 to − 7.42 | < 0.001 | − 18.43 | − 20.56 to − 16.30 | < 0.001 |
Clinical characteristics | ||||||
Age | 0.23 | 0.03–0.44 | 0.027 | 0.16 | − 0.07 to 0.38 | 0.174 |
Sex (female) | 2.92 | − 0.19 to 6.03 | 0.066 | 3.20 | − 0.17 to 6.57 | 0.063 |
BMI | − 0.88 | − 1.18 to − 0.57 | < 0.001 | − 0.83 | − 1.17 to − 0.50 | < 0.001 |
Agatston Score | 0.00 | − 0.00 to 0.00 | 0.423 | 0.00 | − 0.00 to 0.00 | 0.704 |
Atrial fibrillation | 2.37 | − 0.80 to 5.55 | 0.143 | 3.40 | − 0.05 to 6.84 | 0.053 |
Ejection fraction (normal (> 50%)) | Ref | |||||
Moderately reduced (41–50%) | − 0.73 | − 5.34 to 3.89 | 0.758 | − 2.33 | − 7.34 to 2.68 | 0.361 |
Reduced (31–40%) | − 2.89 | − 8.93 to 3.15 | 0.348 | − 4.17 | − 10.72 to 2.39 | 0.213 |
Severely reduced (< 30%) | 5.04 | − 1.70 to 11.78 | 0.142 | 6.32 | − 0.99 to 13.63 | 0.090 |
SNR, signal-to-noise ratio; CNR, contrast-to-noise ratio; BMI, body mass index